** Citi highlights dairy co The A2 Milk Company ATM.NZ, A2M.AX for potential growth, following positive indicators from peer Health and Happiness (H&H) International's 1112.HK full-year results
** Says H&H's report suggests industry volume declines in the super premium segment have stabilised towards year-end, possibly reflecting the strong 2024 birth rate
** Citi emphasises significance of these results for ATM's premium Genesis line, which should benefit from potentially less price-competitive market environment
** Maintains "buy" rating; ASX-listed shares' PT of A$8.20
** ATM up 36.8% YTD
(Reporting by Kumar Tanishk and Nikita Maria Jino in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。